Nu Skin Stockholders Approve Incentive Plan, Authorizing 2.85M New Shares
NUS is trading near its 52-week low of $5.62 (3.0% above the low).
Summary
Nu Skin stockholders have approved an amended omnibus incentive plan, authorizing an additional 2.85 million shares for issuance and extending the plan's termination to 2036. This approval, which follows the proposal outlined in the April 3rd DEF 14A filing, represents potential dilution of nearly 6% based on the company's current market capitalization. This material dilution comes as the company faces significant challenges, including a 12% revenue decline in Q1 2026 and its stock trading near 52-week lows.
At the time of this announcement, NUS was trading at $5.79 on NYSE in the Trade & Services sector, with a market capitalization of approximately $281.1M. The 52-week trading range was $5.62 to $14.62. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.